Form 8-K · Current report
News Corp 8-K, filed Aug 18, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000182
Summary
News Corp reported daily ASX buy-back transactions under its 2025 Repurchase Program, which authorizes up to US$1 billion of Class A and Class B common stock, including 62,323 shares bought back on August 17, 2026 for about US$1.79 million.
Key points
- The 2025 Repurchase Program authorizes up to US$1 billion in aggregate of News Corp's Nasdaq-listed Class A and Class B common stock; no ASX-listed CDIs will be repurchased.
- On August 17, 2026, News Corp bought back 62,323 Class A common shares for total consideration of US$1,794,914.86, at prices between US$28.58 and US$29.14.
- Before that day, cumulative buy-backs totaled 10,842,150 shares for US$277,834,354.15.
- To date, News Corp has purchased approximately US$428,551,639 worth of Class A and Class B shares under the 2025 Repurchase Program.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.